AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers
Advanced Search

Presentation Information

12:45 PM - 1:15 PM JST(3:45 AM - 4:15 AM UTC)

[L1-02]Development of LNP-mRNA vaccine against COVID-19

*Shoji Hirashima1 (1. Representative Director, Head of JBU, Daiichi Sankyo Co., LTD. (Japan))

Login required to view

Login is required to view some content.
Log in

Comment

To browse or post comments, you must log in.Log in

Back to Session information